QUANTUM – DRIVEN THERANOSTICS PLATFORM
QUANTALPHA
THERANOSTICS
Building the Quantum Future of Theranostics
VISION & MISSION
The quantalpha Foundation supports a new era of cancer care
Recognizing a paradigm shift in cancer care to a personalized approach, the QUANTALPHA Foundation´s vision is to scale global patient access to Radiomolecular Precision Oncology – also known as Theranostics – building a future where all patients in need can benefit from this innovative, highly targeted therapy with low side effects, improved efficacy and better patient outcomes.
NEWS
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry’s standard dummy text ever since the 1500s
QUANTALPHA
Building QUANTALPHA Global Centers of Excellence Network
With the aspiration of treating 1 million patients worldwide with high standards of care, ICPO is building a strong…
NET Patient Josh Mailman Featured on NBC Bay Area During Cancer Survivor Month
Today, he continues to live an active life as a dedicated patient advocate, raising awareness of neuroendocrine tumors…
New QUANTALPHA Initiative: Fostering Center-to-Center Best Practices Exchange and Innovation Awareness
ADVANTAGES FOR PARTICIPATING ICPO CENTERS The program offers direct knowledge exchange with leading…
KEY ACTIVITIES OF the QUANTALPHA
QUANTALPHA THERANOSTICS
QUANTALPHA Theranostics Centers
QUANTALPHA THERANOSTICS
QUANTALPHA Research Support
QUANTALPHA
QUANTALPHA THERANOSTICS
QUANTALPHA Academy for Theranostics
QUANTALPHA THERANOSTICS
QUANTALPHA Community & Events
ADVANCING THERANOSTICS TOGETHER
We extend our sincere gratitude to our corporate supporters and cooperation partners for their contribution to our mission. Their commitment enables us to foster excellence in clinical care, provide internationally recognized education, and unlock innovation. Together, we are driving worldwide sustainable impact for cancer patients treated with Theranostics.
Corporate Supporters
QUANTALPHA THERANOSTICS CENTERS OF EXCELLENCE NETWORK
The QUANTALPHA Foundation supports Theranostics centers worldwide – particularly in low- and middle-income countries – to improve clinical practice, accelerate education, and drive innovation. In this respect accredited QUANTALPHA Theranostics Centers of Excellence (CoE) form the cornerstone of our global effort to increase equitable access to high-quality Theranostics. By joining the QUANTALPHA network, Theranostics centers benefit from an accreditation scheme aligned with international standards and shared values from the world‘s leading nuclear medicine societies.